AbbVie
ABBV
#31
Rank
S$415.19 B
Marketcap
$234.95
Share price
-1.23%
Change (1 day)
7.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$0.19 B-13.93%
2023S$0.22 B-63.52%
2022S$0.62 B629.28%
2021S$86.13 M-77.97%
2020S$0.39 B85.64%
2019S$0.21 B-52.97%
2018S$0.44 B269.88%
2017S$0.12 B-48.45%
2016S$0.23 B-37.53%
2015S$0.37 B-44.13%
2014S$0.67 B2387.79%
2013S$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
S$37.96 MS$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.19 BS$0.47 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$74.57 MS$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$36.44 MS$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$36.09 MS$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$25 MS$71.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$96.61 MS$0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
S$53.97 MS$0.19 B๐Ÿ‡ฌ๐Ÿ‡ง UK
S$5.15 MS$24.58 M๐Ÿ‡บ๐Ÿ‡ธ USA